See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI102.05▲ 2.59%
← AMS page
XStocksXray
Market X-Ray report · 22 October 2026

Ams AG (AMS)

SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026

Key indicators

Last closeCHF 17.71
52-week range6.85 – 25.50
Return, 1 month / 3 months−16.8% / +3.6%
Return, 1 year / 3 years+44.1% / −9.1%
TrendAbove 200-day, below 50-day
RSI (14)41
Volatility (1 year)83.2%
Worst drawdown (1 year)-44.3%
Average daily value traded12.48M CHF
Dividend yield–

Market X-Ray price-based

58/ 100 · High confidence · ahead of 60% of stocks on this exchange
Trend68
Momentum83
Stability (higher is calmer)9
Liquidity81
Income–

Five-year price chart navy: price · brown: 200-day average

-0.5426.1152.7779.421062021-102023-012024-042025-072026-10

About the company

ams AG is a sensor company based in Austria that designs and manufactures optical, image, light and audio sensors. Its components are used in smartphones, consumer electronics, cars and industrial equipment, where they measure light, distance, colour and sound. The company supplies device makers and automotive and industrial customers around the world, and its products sit inside cameras, displays and sensing systems rather than being sold directly to consumers.

On this site Ams AG appears as a stock on the SIX Swiss Exchange (Switzerland), code AMS, with prices in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Ams AG (AMS) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 17.71 on 22 October 2026.

Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 91 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 44.1% and over the last three months it rose 3.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Ams AG (AMS)

The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange

Lens and metricValueScoreReading
Trend68 · FairMixed trend against its averages.
Above 200-day average19.4%
From 52-week high-29.1%
Momentum83 · StrongRising faster than most stocks on this exchange.
3-month return3.6%
6-month return42.7%
12-month return, skipping the last month73.1%
Stability (higher is calmer)9 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)83.2%
Worst drawdown, 1 year (smaller is calmer)-44.3%
Liquidity81 · StrongTrades actively.
Average daily value traded12.48M CHF
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−3.0%
1 month−16.8%
3 months+3.6%
6 months+42.7%
1 year+44.1%
3 years−9.1%
5 years−81.1%

Signals

50-day / 200-day average19.29 / 14.84
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.40

Technical summary

DailyBearish5 bullish · 1 neutral · 10 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026